Intersect ENT Inc

Intersect ENT Inc

XENT - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$952.68M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Intersect ENT IncIntersect ENT Inc-5.9-181%9.4-1.7
$29.39

Current Fair Value

4.1% upside

Undervalued by 4.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$952.68 Million
Enterprise Value$1.08 Billion
Earnings per Share$-4.8
Beta1.53
Outstanding Shares33,735,000

Return

Return on Equity181.29%ROE
Return on Assets-133.81%
Return on Invested Capital-200.74%

Valuation & Multiples

P/E Ratio-5.88P/E Ratio
PEG-10.88PEG
Price to Sales9.41Price to Sales
Price to Book Ratio-9.41Price to Book Ratio
Enterprise Value to Revenue10.43
Enterprise Value to EBIT-6.67
Enterprise Value to Net Income-7
Total Debt to Enterprise0.15
Debt to Equity-1.68Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Intersect ENT Inc

CEO: Thomas West

Intersect ENT Insider Information FAQ

In the latest 13F quarter on Stockcircle, 4 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.